Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics, Inc. (RAPT) Total Current Liabilities (2020 - 2024)

RAPT Therapeutics' Total Current Liabilities history spans 5 years, with the latest figure at $10.4 million for Q3 2024.

  • For Q3 2024, Total Current Liabilities changed N/A year-over-year to $10.4 million; the TTM value through Sep 2024 reached $10.4 million, changed N/A, while the annual FY2023 figure was $21.8 million, 53.52% up from the prior year.
  • Total Current Liabilities for Q3 2024 was $10.4 million at RAPT Therapeutics, down from $14.8 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $21.8 million in Q4 2023 and bottomed at $9.6 million in Q4 2021.
  • The 5-year median for Total Current Liabilities is $13.3 million (2020), against an average of $14.2 million.
  • The largest annual shift saw Total Current Liabilities dropped 20.54% in 2021 before it surged 74.82% in 2023.
  • A 5-year view of Total Current Liabilities shows it stood at $11.7 million in 2020, then dropped by 18.28% to $9.6 million in 2021, then soared by 48.24% to $14.2 million in 2022, then surged by 53.52% to $21.8 million in 2023, then tumbled by 52.55% to $10.4 million in 2024.
  • Per Business Quant, the three most recent readings for RAPT's Total Current Liabilities are $10.4 million (Q3 2024), $14.8 million (Q2 2024), and $21.2 million (Q1 2024).